Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CVS HealthCVS +1.37%81 EV-to-OCF is 12.43 as of Aug. 12, 2026, which is 3% above its 10-year median of 12.11. GuruFocus rates CVS with a GF Score™ of 81/100 and a GF Value™ of $78.70 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, CVS Health ranks worse than 55.56% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, CVS Health's Enterprise Value is $183,766 Mil.
CVS Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $14,780 Mil. Therefore, CVS Health's EV-to-OCF for today is 12.43.
The historical rank and industry rank for CVS Health's EV-to-OCF or its related term are showing as below:
CVS'
s EV-to-OCF Range Over the Past 10 Years
Min: 7.29 Med: 12.11 Max: 34.06
Current: 12.43
During the past 13 years, the highest EV-to-OCF of CVS Health was 34.06. The lowest was 7.29. And the median was 12.11.
CVS's EV-to-OCF is ranked worse than 55.56% of 18
companies
in the Healthcare Plans industry
Industry Median: 11.92
vs CVS: 12.43
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CVS Health's share price for today is $94.78.
CVS Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.780.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CVS Health EV-to-OCF Related Terms
CVS Health EV-to-OCF Historical Data
* Premium members only.
The historical data trend for CVS Health's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, CVS Health's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Health EV-to-OCF vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, CVS Health's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where CVS Health's EV-to-OCF falls into.
CVS Health's current Enterprise Value is $183,766 Mil.
CVS Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $14,780 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Health (CVS) has a EV-to-OCF of 12.43 as of Aug. 12, 2026. This is near median its historical median of 12.11. Over the past decade, CVS Health's EV-to-OCF has ranged from 7.29 to 34.06. According to the industry distribution chart, CVS Health ranks #10 out of 18 companies in the Healthcare Plans industry, placing it in the top 55.6%.
Is CVS Health's EV-to-OCF too high?
CVS Health's current EV-to-OCF of 12.43 is near median its 10-year median of 12.11. Over the past 10 years, this metric has ranged from a low of 7.29 to a high of 34.06. The Healthcare Plans industry median EV-to-OCF is 11.92. CVS Health's value of 12.43 is 4.3% above this industry median. Based on the distribution chart, CVS Health ranks #10 out of 18 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, CVS Health has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's EV-to-OCF compare to ELV and CI?
According to the Healthcare Plans industry distribution chart, CVS Health ranks #10 out of 18 companies for EV-to-OCF. This places CVS Health in the lower half of its industry. The industry median EV-to-OCF is 11.92. CVS Health's value of 12.43 is 4.3% above this benchmark. Historically, CVS Health's own EV-to-OCF has ranged from 7.29 to 34.06 over the past decade. While the company's 10-year median is 12.11 vs. the industry median of 11.92, CVS Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Plans company?
The median EV-to-OCF among Healthcare Plans companies is 11.92, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Health's current EV-to-OCF of 12.43 is 4.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median EV-to-OCF is 11.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Health's current EV-to-OCF is 12.43, which is near median its own 10-year median of 12.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (CVS) is currently considered Modestly Overvalued. The stock's GF Value™ is $78.70, compared to a current price of $94.78 — trading 20.4% above its estimated fair value. The current EV-to-OCF is 12.43, which is near median its 10-year median of 12.11 and 4.3% above the Healthcare Plans industry median of 11.92. CVS Health's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For CVS Health (CVS), the current EV-to-OCF is 12.43 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Health (CVS) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Health stock appears to be overvalued.
The current stock price of $94.78 is trading 20.4% above its estimated GF Value™ of $78.70.
GuruFocus considers CVS Health to be Modestly Overvalued.
Key valuation signals for CVS:
EV-to-OCF: 12.43 (near median its 10-year median of 12.11)
GF Value™: $78.70 vs. price of $94.78 (20.4% above fair value)
Industry Position: 4.3% above the Healthcare Plans median (#10 of 18)
No single metric tells the full story. See the CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
81GF Score
Get the complete analysis for CVS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVS has been successfully added to your 
